Manufacturing Facilities
World’s largest cGMP API and Intermediates manufacturing facility.
MANUFACTURING FACILITIES
World’s largest cGMP API and Intermediates manufacturing facility.
Divi’s currently operated three manufacturing sites near Hyderabad and Visakhapatnam in India. The third manufacturing facility, near Kakinada, India, commenced commercial operations in January,2025.
The three manufacturing units have more than 70 production buildings and 68 pharma suits with a total reaction capacity of more than ~16,500m3, making them the largest API manufacturing facilities in the world.
The pilot plants at Divi’s are capable of handling high potent products (Products with exposure level up to 10mcg/m3) and several low dose products under cGMP.
Divis is Commercial-scale manufacturer of non-potent & highly potent APIs to deliver from gram scale to 1000’s of tons under cGMP.
Divi’s pharma areas comply with class 100, 000 clean air requirement and each pharma will have suitable filtration and drying equipment like centrifuge, ANFD, VTDR, RCVD, milling and sieving equipment’s.
KILO LABS
- Kilo Lab (cGMP)
- Flexible, Multi-purpose
- Scale-up studies
- Production of 1 kg to 10 kg batch size
PILOT PLANTS
- Physical segregation and containment for processing and isolation
- Containment systems are in place to handle the hazardous reactions
- All pilot plants are equipped with cryogenic, high temperature and high vacuum capabilities and offer a broad range of isolation equipment
COMMERCIAL SCALE
- Multipurpose production facilities offering greater flexibility
- Special Production Blocks to handle pyrophoric reactions, high energetic, Azide chemistry, High Pressure with fool proof safety requirements
- Batch sizes as large as 6 MT
Manufacturing Plants Overview
UNIT-1
Total Land: 500 Acres (2 sq. kms)
CAPACITY : ~4,600m3
Manufacturing Facility Near Hyderabad
INFRASTRUCTURE:
- Land : 500 Acres (2 sq. kms)
- Production Blocks : 26
CAPACITY:
- Reactors : Over 700
- Capacity: ~ 4600 m3
REGULATORY INSPECTIONS:
- USFDA
- EU GMP
- JAPAN PMDA
- MFDS(K FDA)
- COFEPRIS
UNIT-II
Total Land: 500 Acres (2 sq. kms)
CAPACITY : ~10,500m3
Manufacturing Facility Near Visakhapatnam
INFRASTRUCTURE:
- Land : 500 Acres (1.8 sq. kms)
- Production Blocks : 40
CAPACITY:
- Reactors : Over 1100
- Capacity: ~ 10500 m3
REGULATORY INSPECTIONS:
- USFDA
- MHRA (UK)
- JAPAN PMDA
- MFDS(Koriea FDA)
- COFEPRIS
- TGA (Australia)
UNIT-III
Total Land: 500 Acres (2 sq. kms)
CAPACITY : 1,450 m3(Phase I)
Manufacturing Facility Near Kakinada (Under progress)
2025
- Commenced commercial operations
2019
- Setting up of Unit – III Manufacturing Site at Kakinada